Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
464 Patents
#199 in Tokyo
#399 in Japan
#2,054 in the World
Daiichi Sankyo Company, Limited
Forward Citations = 1,574
902 inventors:
Daiichi Sankyo Company, Limited
Calculating rank
% Expired Patents = 33.6
CIPO Patents = 66
EPO Patents = 300
Trademarks = 103
Forward Citations = 1,574
Loading Chart...
Loading Chart...
902 inventors (with patents filed for the assignee):
Kensuke Nakamura (27 out of 43 patents)
Kazumasa Aoki (20 out of 35 patents)
Takeshi Masuda (18 out of 51 patents)
4. Yuji Kasuya (18 out of 23 patents)
5. Shinji Ashida (17 out of 17 patents)
6. Takashi Nakada (16 out of 19 patents)
7. Koji Morita (16 out of 42 patents)
8. Makoto Koizumi (16 out of 53 patents)
9. Katsuyoshi Nakajima (14 out of 17 patents)
10. Keiji Saito (14 out of 26 patents)
11. Yasuyuki Ogawa (14 out of 36 patents)
12. Hiroyuki Naito (13 out of 46 patents)
13. Yusuke Ogitani (13 out of 13 patents)
14. Daisuke Nishimiya (12 out of 12 patents)
15. Masao Yoshida (12 out of 31 patents)
Core Competencies:
Antibody-Drug Conjugate
Cancer Treatment
Biomarker
HER3
MUC1
LAG-3
CDH6
Immune Checkpoint Inhibitor
Peptide
Nucleic Acid
Tumor
Glycogen Storage Disease
464 patents:
4. 12728150 - Combination pharmaceutical of temozolomide and mutant IDHI enzyme inhibitor (2026-09-08),
Company Overview
Daiichi Sankyo Company, Limited, headquartered in Tokyo, Japan, is a global pharmaceutical company focused on innovative drug development. The company specializes in antibody-drug conjugates, a cutting-edge approach in cancer treatment that combines targeted therapy with potent cytotoxic agents. Daiichi Sankyo is actively engaged in research related to various biomarkers, including HER3, MUC1, LAG-3, and CDH6, as well as immune checkpoint inhibitors, aiming to enhance therapeutic options for patients with cancer.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Daiichi Sankyo Company, Limited. Retrieved from https://idiyas.com/company/daiichi-sankyo-company
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
66 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
300 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]